Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Frequency Therapeutics, Inc.    FREQ

FREQUENCY THERAPEUTICS, INC.

(FREQ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/15/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
35.85(c) 38.39(c) 37.78(c) 35.8(c) 38.73(c) Last
184 789 194 368 208 897 241 484 214 094 Volume
-2.48% +7.09% -1.59% -5.24% +8.18% Change
More quotes
Financials (USD)
Sales 2020 35,4 M - -
Net income 2020 -25,7 M - -
Net cash position 2020 211 M - -
P/E ratio 2020 -48,9x
Yield 2020 -
Sales 2021 66,3 M - -
Net income 2021 -1,23 M - -
Net cash position 2021 176 M - -
P/E ratio 2021 1 549x
Yield 2021 -
Capitalization 1 307 M 1 307 M -
EV / Sales 2020 30,9x
EV / Sales 2021 17,0x
Nbr of Employees 45
Free-Float 77,9%
More Financials
Company
Frequency Therapeutics Inc. is a United States-based clinical-stage progenitor cell activation (PCA) regeneration company. The Company is focused on developing small molecule drugs that activate progenitor cells within the body to restore healthy tissue. It uses its PCA technology to develop a pipeline of progenitor cell activators. It focuses on various therapeutic areas, such as hearing loss, skin disorders,... 
More about the company
Notations Surperformance© of Frequency Therapeutics, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about FREQUENCY THERAPEUTICS, INC.
01/20FREQUENCY THERAPEUTICS : Appoints Quentin McCubbin Ph.D. as Chief Manufacturing ..
AQ
01/19FREQUENCY THERAPEUTICS : Appoints Quentin McCubbin, Ph.D., as Chief Manufacturin..
BU
01/11FREQUENCY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements an..
AQ
01/05FREQUENCY THERAPEUTICS : to Present 2021 Business and Pipeline Overview at the 3..
BU
2020FREQUENCY THERAPEUTICS : B. Riley Starts Frequency Therapeutics at Buy With $79 ..
MT
2020FREQUENCY THERAPEUTICS : to Host Investor Event on the Potential for Restorative..
AQ
2020FREQUENCY THERAPEUTICS : to Host Investor Event on the Potential for Restorative..
BU
2020FREQUENCY THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, F..
AQ
2020FREQUENCY THERAPEUTICS : Oppenheimer Adjusts Frequency Therapeutics PT to $48 Fr..
MT
2020FREQUENCY THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creat..
AQ
2020Frequency Therapeutics Names Peter Pfreundschuh as Chief Financial Officer
MT
2020FREQUENCY THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financ..
AQ
2020Frequency Therapeutics Names Peter Pfreundschuh CFO
MT
2020FREQUENCY THERAPEUTICS : Appoints Peter Pfreundschuh as Chief Financial Officer
BU
2020Frequency Therapeutics Provides Business Updates and Reports Third Quarter 20..
AQ
More news
News in other languages on FREQUENCY THERAPEUTICS, INC.

- No features available -

More news
Analyst Recommendations on FREQUENCY THERAPEUTICS, INC.
More recommendations
Chart FREQUENCY THERAPEUTICS, INC.
Duration : Period :
Frequency Therapeutics, Inc. Technical Analysis Chart | FREQ | US35803L1089 | MarketScreener
Technical analysis trends FREQUENCY THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 47,00 $
Last Close Price 38,73 $
Spread / Highest target 104%
Spread / Average Target 21,4%
Spread / Lowest Target -30,3%
EPS Revisions
Managers and Directors
NameTitle
David L. Lucchino President, Chief Executive Officer & Director
Marc A. Cohen Executive Chairman
Richard Mitrano Vice President-Finance & Operations
Peter P. Pfreundschuh Chief Financial Officer
Christopher R. Loose Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
FREQUENCY THERAPEUTICS, INC.9.84%1 307
MODERNA, INC.25.41%51 846
LONZA GROUP AG5.34%50 271
CELLTRION, INC.-13.65%38 245
IQVIA HOLDINGS INC.3.58%35 582
SEAGEN INC.4.35%33 059